CIK 0001226616 · Non-accelerated filer<br>Smaller reporting company
MEDICINOVA INC
Sign in to watch- Ticker
- MNOV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330927979
- Phone
- 858-373-1500
- Business address
- 4275 EXECUTIVE SQUARE, SUITE 300, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,728,000
- in 1 filing
Net −$1,728,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-28 | Okajima Masatsune VP and Head of Japanese Office | Option exercise · Employee Stock Option (Right to Buy) | −105,000 | 0 | ||
| 2019-02-28 | Okajima Masatsune VP and Head of Japanese Office | Option exercise · Employee Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2019-02-28 | Okajima Masatsune VP and Head of Japanese Office | Option exercise · Employee Stock Option (Right to Buy) | −105,000 | 0 | ||
| 2019-02-28 | Okajima Masatsune VP and Head of Japanese Office | Option exercise · Employee Stock Option (Right to Buy) | −30,000 | 0 | ||
| 2019-02-28 | Okajima Masatsune VP and Head of Japanese Office | Option exercise · Employee Stock Option (Right to Buy) | −120,000 | 0 | ||
| 2019-02-28 | Okajima Masatsune VP and Head of Japanese Office | Option exercise · Employee Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2019-02-28 | Okajima Masatsune VP and Head of Japanese Office | Option exercise · Employee Stock Option (Right to Buy) | −105,000 | 0 | ||
| 2019-01-15 | Okajima Masatsune VP and Head of Japanese Office | Grant or award · Employee Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2019-01-15 | OBrien Geoffrey Vice President | Grant or award · Employee Stock Option (Right to Buy) | +205,000 | 205,000 | ||
| 2019-01-15 | Matsuda Kazuko Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +295,000 | 295,000 | ||
| 2019-01-15 | IWAKI YUICHI President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +470,000 | 470,000 | ||
| 2019-01-09 | Okajima Masatsune VP and Head of Japanese Office | Option exercise | +41,250 | $2.20 | $91K | 153,580 |
| 2019-01-09 | Okajima Masatsune VP and Head of Japanese Office | Option exercise · Employee Stock Option (Right to Buy) | −41,250 | 0 | ||
| 2019-01-03 | IWAKI YUICHI President and CEO | Option exercise | +18,572 | $2.20 | $41K | 759,392 |
| 2019-01-03 | IWAKI YUICHI President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −18,572 | 0 | ||
| 2018-06-07 | Nagao Hideki Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2018-06-07 | Kobayashi Yutaka Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2018-06-07 | Ishizaka Yoshio Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2018-03-05 | IWAKI YUICHI President and CEO | Option exercise | +50,003 | $2.20 | $110K | 740,594 |
| 2018-03-05 | IWAKI YUICHI President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −50,003 | 0 |
Page 6 of 8 · 149 trades